Michael Kramer

Michael Kramer

Michael Kramer is the Founder of Mott Capital Management. His unique investment philosophy centers on seeking investment opportunities that are influenced by everyday life activities, and by observing new trends and products that are popular or are trending towards popularity. Additionally, he devotes a significant part of his research to global macroeconomics and central bank policies impacting financial markets.

Kramer runs the Mott Capital Management actively managed long-only Thematic Growth Portfolio, which holds these stocks: AAPL, ACAD, ALKS, CELG, DEO, DIS, GOOGL, MA, MO, NFLX, NXPI, RTN, SWKS TSLA, UL, V, VOD and VZ.

Kramer began his career in high-risk trading environments, trading both US and international equities. His trading skills coupled with his comprehensive, financial analysis of public companies, have given him a unique perspective on investing, which stands out from analysts who simply look at top-line numbers. In addition to fundamental analysis, Kramer also incorporates technical and options market analysis into his research.

Kramer is a fundamental writer for Investopedia.com, analyzing stocks and market news that is helpful for everyday investors to make short and long-term investment decisions.

  1. Stocks

    Biotech Celgene's Stock Seen Rebounding 14%

    Celgene Corp.'s stock appears to be on the mend after falling by more than 40% since October.
  2. Stocks

    Why Macy's Stock Faces More Steep Declines

    Macy's stock has soared 40% in 2018, far outperforming the market.
  3. Stocks

    Johnson & Johnson's Breakout May Boost Stock 11%

    Johnson & Johnson's stock has fallen 14% off its high this year.
  4. Stocks

    Netflix Traders Bet Stock Will Gain 10% After Results

    Options traders are betting shares of Netflix could increase by another 10% following quarterly results.
  5. Stocks

    Disney Traders Bet Stock Will Rally 6% Short Term

    Disney shares have significantly underperformed the S&P 500 in the past year.
  6. Stocks

    Merck Stock Seen Rising 12% on Faster Profit Growth

    Merck's stock already has risen 10% this year, outperforming the broader market.
  7. Stocks

    Why Micron's Stock May Rebound 10%

    Micron Technology Inc.'s stock may be ready to rebound by roughly 10% in the coming weeks.
  8. Stocks

    Wells Fargo Stock May Fall 7% Amid Tepid Growth

    Options traders are overwhelmingly bearish on Wells Fargo's stock.
  9. Stocks

    Starbucks' Stock May Fall 12% as Outlook Worsens

    Starbucks, already 20% off its highs, faces even steeper declines.
  10. Stocks

    Why McDonalds’ Stock May Suffer a Big Pullback

    The technical charts show that McDonald's stock can't gain any positive momentum and may fall by 8%.
  11. Stocks

    GE Traders See Stock Rising 10% as Estimates Rise

    General Electric's stock has fallen 46% in the past year.
  12. Stocks

    NVIDIA Stock May Hit Record High on Profit Growth

    NVIDIA's shares have risen 10-fold in the past three years.
  13. Stocks

    4 Biotechs on Verge of Big Breakouts

    Signs are emerging that the larger-cap biotechs are poised to break out in the near term.
  14. Stocks

    Lululemon's Stock Poised for a 16% Pullback

    Shares of the athletic apparel company are poised to fall by nearly 17% over the short term.
  15. Stocks

    Alibaba Traders Bet on 15% Rise Despite Red Flags

    Alibaba's stock has sharply lagged the S&P 500 index in recent months.